Chemo-Free Drug, Tecvayli, Shows Major Survival, Remission Gains In Relapsed Multiple Myeloma
WEDNESDAY, June 3, 2026 — A recently approved cancer immunotherapy can put nearly two-thirds of people with relapsed multiple myeloma into complete remission, a new clinical trial has found.
About 70% of patients treated with teclistamab...
Read more »
Pharmaceutical news
Prayer at Primary Care Appointments Tied to Reductions in Pain, Anxiety
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2
Dengue Is No Longer Just A Travel Risk — What Google’s Mosquito Plan Could Mean For Your Summer
ASCO: Tile-Based Radiation Beneficial for Newly Resectable Brain Mets
ASCO: Apalutamide + ADT Beneficial in High-Risk Localized Prostate Cancer
Wearable Ultrasound Patch Provides Continuous Fetal Monitoring
Cardiometabolic Genetics Linked to Cognitive-Related Outcomes
Dose Reduction of Biologics Effective, Safe for Psoriasis
Brain Surgery For Pituitary Tumor Helps Illinois Mom Have Second Baby
Spinal Cord Stimulation May Restore Arm Strength After Stroke
Popular Blood Pressure Meds Linked To Kidney Damage Risk In Type 2 Diabetes
Popular Blood Pressure Meds, Dihydropyridine Calcium-Channel Blockers, Linked To Kidney Damage Risk In Type 2 Diabetes
Too Much Sitting In Pregnancy Doubles Risk Of Complications
Two-Pill Combo Offers Hospital-Free Leukemia Treatment Option For Older Adults With AML
